← Back to Adjuvant Capital profile
Adjuvant Capital related stories
All articles and analysis
InDevR pulls in $7 mln Series ABoulder, Colorado-based InDevR Inc, a biotechnology company, has raised $7 million in Series A funding. The investor was Adjuvant Capital.
- X-Vax rakes in $56 mln
Jupiter, Florida-based X-Vax Technology Inc, a herpes vaccines developer, has raised $56 million in funding. The investors included Johnson & Johnson Innovation – JJDC, Inc., Adjuvant Capital, Serum Institute of India, Alexandria Venture Investments and FF DSF VI.